Overexpression of PLK1 is associated with poor survival by inhibiting apoptosis via enhancement of survivin level in esophageal squamous cell carcinoma
✍ Scribed by Yan-Bin Feng; De-Chen Lin; Zhi-Zhou Shi; Xiao-Chun Wang; Xiao-Ming Shen; Yu Zhang; Xiao-Li Du; Man-Li Luo; Xin Xu; Ya-Ling Han; Yan Cai; Zi-Qiang Zhang; Qi-Min Zhan; Ming-Rong Wang
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- French
- Weight
- 696 KB
- Volume
- 124
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
PLK1 is essential for the maintenance of genomic stability during mitosis. In our study, we found that overexpression of PLK1 was an independent prognostic factor (RR = 4.253, p = 0.020) and significantly correlated with survivin, an antiapoptotic protein, in esophageal squamous cell carcinoma (ESCC). Reverse transcription‐polymerase chain reaction and fluorescence in situ hybridization (FISH) revealed upregulation of PLK1 mRNA and amplification of PLK1 gene, respectively. Depletion of PLK1 activated the intrinsic apoptotic pathway, which was substantiated by loss of mitochondrial membrane potential, reduction of Mcl‐1 and Bcl‐2 as well as activation of caspase‐9. Coimmunoprecipitation and confocal microscopy displayed that PLK1 was associated with survivin and PLK1 depletion led to downregulation of survivin. Cotransfection of survivin constructs could partially reverse PLK1‐depletion‐induced apoptosis. These data suggest that PLK1 might be a useful prognostic marker and a potential therapeutic target for ESCC. Survivin is probably involved in antiapoptotic function of PLK1. © 2008 Wiley‐Liss, Inc.